Fidelis Pharmaceuticals
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
675 US Highway 1 Ste B113, North Brunswi...Phone Number
(833) 384-4729Website
www.ethiqaxr.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Fidelis Pharmaceuticals
Ethiqa XR specializes in providing extended-release buprenorphine for veterinary and research use, delivering up to 72 hours of pain relief with a single injection. The product is FDA-indexed and designed for the control of post-procedural pain in captive rodents, ferrets, laboratory rabbits, and non-human primates. Their intended clients include laboratory veterinarians, exotic vet practitioners, and zoo vet husbandry professionals. Ethiqa XR is committed to supporting animal welfare through science-backed pain management solutions.Explore more
Popular SearchesFidelis Pharmaceuticals LLCFidelis Pharmaceuticals IncEthiqaxrFidelis Pharmaceuticals| LLCSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fidelis Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Fidelis Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Fidelis Pharmaceuticals is spiking on competitors!
Click to see if Fidelis Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Fidelis Pharmaceuticals
Fidelis Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Fidelis Pharmaceuticals has new funding data
Earning: See what the market has to say on Fidelis Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Fidelis Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Fidelis Pharmaceuticals
Compare insights from companies similar to Fidelis Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Fidelis Pharmaceuticals
<$5M
1-10
Private
-
2019
N/A
Company Profile Activity
Activity Insights
Fidelis Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Fidelis Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fidelis Pharmaceuticals.
Fidelis Pharmaceuticals Tech Stack
A closer look at the technologies used by Fidelis Pharmaceuticals
Fidelis Pharmaceuticals News & Media
Fidelis Pharmaceuticals Announces Name Change to Reflect Corporate Focus
Fidelis Animal Health, Inc. is the new name of Fidelis Pharmaceuticals, Inc., under which it will be developing and commercializing products that utilize its proprietary extended-release technology as well as seeking to expand into other animal welfare solutions. NORTH BRUNSWICK, N.J. ,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fidelis Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Ethiqa XR specializes in providing extended-release buprenorphine for veterinary and research use, delivering up to 72 hours of pain relief with a single injection. The product is FDA-indexed and designed for the control of post-procedural pain in captive rodents, ferrets, laboratory rabbits, and non-human primates. Their intended clients include l... Read More
